{
    "nctId": "NCT01781299",
    "briefTitle": "Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU",
    "officialTitle": "Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Mastectomy",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 9,
    "primaryOutcomeMeasure": "Complication Rates",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Subject's with ability to provide informed consent.\n2. Subjects greater than 18 years old\n3. Subjects to undergo an immediate tissue expander reconstruction following mastectomy; and\n4. Subjects who are, in the opinion of the Investigator, able to understand the study, comply with the study design and are willing to return to the clinic for all the research required follow-up visits.\n\nExclusion Criteria:\n\n1. Subjects less than 18 years of age\n2. Subjects that based on surgeon's discretion cannot be effectively reconstructed with the use of ADM product\n3. Pregnancy\n4. Bovine allergy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}